Pro Dex (PDEX) Cash from Financing Activities (2010 - 2026)
Pro Dex's (PDEX) quarterly Cash from Financing Activities came in at -$1.7 million in Q2 2026, up 40.26% year-over-year from -$1.2 million in Q2 2025, and down 131.6% quarter-over-quarter from $5.5 million in Q1 2026.
Powered by 
Analysis
Pro Dex (PDEX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Pro Dex has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$1.7 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities rose 40.26% year-over-year to -$1.7 million; the TTM figure through Jun 2026 stood at -$3.4 million (down 1058.22% YoY), while the FY2026 annual figure was -$3.4 million, down 1058.22% from the prior year.
- Cash from Financing Activities came in at -$1.7 million for Q2 2026 at Pro Dex, down from $5.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $5.5 million in Q1 2026 to a low of -$5.0 million in Q4 2025.
- Average Cash from Financing Activities over 5 years is -$555111.1, with a median of -$929500.0 recorded in 2022.
- The largest YoY upside for Cash from Financing Activities was 200.54% in 2024 against a maximum downside of 509.12% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$1.5 million in 2022, then jumped by 136.88% to $558000.0 in 2023, then surged by 200.54% to $1.7 million in 2024, then plunged by 398.21% to -$5.0 million in 2025, then jumped by 65.49% to -$1.7 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$1.7 million in Q2 2026, $5.5 million in Q1 2026, and -$5.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Pro Dex | 192.84 Mn | 183.45 Mn | 7.09 Mn | -1.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.73 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | -5.00 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | 558,000.00 |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | 373,000.00 |
| Mar 31, 2023 | -497,000.00 |
| Dec 31, 2022 | -1.51 Mn |
| Sep 30, 2022 | -853,000.00 |
| Jun 30, 2022 | 966,000.00 |
| Mar 31, 2022 | -498,000.00 |
| Dec 31, 2021 | -887,000.00 |
| Sep 30, 2021 | -371,000.00 |